Study of a community mentoring program to boost antiviral defenses
Part of Infections clinical trials.
This study tests whether a community-based, intergenerational mentoring program can help the body’s natural defenses against viruses. You may be able to join if you’re part of the GenX program and meet the basic location and screening requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be enrolled in the GenX intergenerational mentoring program
- You must be a GenX mentor who is older than 50 years
- You must live in the neighborhood around GenX schools in South-Central Los Angeles
- You must be able to pass the program’s basic literacy and thinking (cognitive) tests
- You must not have any health condition that would make participation unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an intergenerational program (between younger and older adults) to help reduce loneliness and social isolation. It asks you to join activities using video on an internet-connected device and to be able to follow study steps safely at home.
This study tracks how respiratory viruses spread in the community and within households. It involves testing and collecting samples from people who are sick or healthy, to help better understand and prevent outbreaks.
This study tests if giving a long-acting HIV prevention shot (lenacapavir) from a mobile medical van can reach people at risk for HIV in Los Angeles County. You may be able to join if you are HIV negative, at risk for HIV, and are willing to try a shot instead of a daily pill.
This trial studies how viruses affect the body, and how the immune system responds, in both healthy people and people with weakened immunity. It may include people who currently have a suspected or recent viral infection, close contacts, people around the time of a viral vaccine, and healthy adults used for comparison.
This trial tests a digital health program (available with limited in-person contact) to help SGM young people reduce their risk of HIV. You may be a good fit if you’re in the right age range and have had certain types of sex in the last 6 months.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
Hear when a new Virus Infection, RNA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.